
Ozempic, other semaglutides linked to hair loss: Here's what to know
Fox News
A recent study linked GLP-1 (glucagon-like peptide-1) agonists — the class of drugs that includes semaglutides — to an increased risk of hair loss. Here's what you should know.
While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked GLP-1 (glucagon-like peptide-1) agonists — the class of drugs that includes semaglutides — to an increased risk of hair loss. "Hair growth (and loss) are quite dependent on factors such as diet, essential vitamins, bodily stress and genetics." "While the rate of incidence of hair loss is still decidedly low, it’s a potential trade-off that a patient should consider." Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
The researchers analyzed data from 16 million patients from a health claims database, narrowing it down to 1,926 semaglutide users and 1,348 users of bupropion-naltrexone, another type of weight-loss medication.